{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:19:11Z","timestamp":1792448351890,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM148182"],"award-info":[{"award-number":["R35GM148182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA056365"],"award-info":[{"award-number":["R01DA056365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001082","name":"Camille and Henry Dreyfus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["XSEDE\/ACCESS program"],"award-info":[{"award-number":["XSEDE\/ACCESS program"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Chem."],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41557-024-01714-7","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T10:02:39Z","timestamp":1738836159000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficient and modular synthesis of ibogaine and related alkaloids"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-4748","authenticated-orcid":false,"given":"Rishab N.","family":"Iyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2435-2898","authenticated-orcid":false,"given":"David","family":"Favela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1722-708X","authenticated-orcid":false,"given":"Andras","family":"Domokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6211-7966","authenticated-orcid":false,"given":"Arabo A.","family":"Avanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2276-4373","authenticated-orcid":false,"given":"Samuel J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-9785","authenticated-orcid":false,"given":"Andrian G.","family":"Basargin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2992-8844","authenticated-orcid":false,"given":"Dean J.","family":"Tantillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-0543","authenticated-orcid":false,"given":"David E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"1714_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1039\/D0NP00033G","volume":"38","author":"RN Iyer","year":"2021","unstructured":"Iyer, R. N., Favela, D., Zhang, G. & Olson, D. E. The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs. Nat. Prod. Rep. 38, 307\u2013329 (2021).","journal-title":"Nat. Prod. Rep."},{"key":"1714_CR2","doi-asserted-by":"publisher","first-page":"108717","DOI":"10.1016\/j.jsat.2021.108717","volume":"138","author":"P Kock","year":"2022","unstructured":"Kock, P., Froelich, K., Walter, M., Lang, U. & Dursteler, K. M. A systematic literature review of clinical trials and therapeutic applications of ibogaine. J. Subst. Abuse Treat. 138, 108717 (2022).","journal-title":"J. Subst. Abuse Treat."},{"key":"1714_CR3","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1021\/acschemneuro.8b00294","volume":"9","author":"MJ Wasko","year":"2018","unstructured":"Wasko, M. J., Witt-Enderby, P. A. & Surratt, C. K. DARK classics in chemical neuroscience: ibogaine. ACS Chem. Neurosci. 9, 2475\u20132483 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"1714_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.71","volume":"6","author":"M Belgers","year":"2016","unstructured":"Belgers, M. et al. Ibogaine and addiction in the animal model, a systematic review and meta-analysis. Transl. Psychiatry 6, e826 (2016).","journal-title":"Transl. Psychiatry"},{"key":"1714_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1369-1600.2012.00447.x","volume":"19","author":"X Koenig","year":"2014","unstructured":"Koenig, X., Kovar, M., Boehm, S., Sandtner, W. & Hilber, K. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk. Addict. Biol. 19, 237\u2013239 (2014).","journal-title":"Addict. Biol."},{"key":"1714_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1124\/jpet.113.209643","volume":"348","author":"P Thurner","year":"2014","unstructured":"Thurner, P. et al. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. J. Pharmacol. Exp. Ther. 348, 346\u2013358 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1714_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1556-4029.2011.02008.x","volume":"57","author":"KR Alper","year":"2012","unstructured":"Alper, K. R., Staji\u0107, M. & Gill, J. R. Fatalities temporally associated with the ingestion of ibogaine. J. Forensic Sci. 57, 398\u2013412 (2012).","journal-title":"J. Forensic Sci."},{"key":"1714_CR8","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/molecules20022208","volume":"20","author":"X Koenig","year":"2015","unstructured":"Koenig, X. & Hilber, K. The anti-addiction drug ibogaine and the heart: a delicate relation. Molecules 20, 2208\u20132228 (2015).","journal-title":"Molecules"},{"key":"1714_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","volume":"589","author":"LP Cameron","year":"2021","unstructured":"Cameron, L. P. et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589, 474\u2013479 (2021).","journal-title":"Nature"},{"key":"1714_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0006-8993(96)00056-X","volume":"719","author":"SD Glick","year":"1996","unstructured":"Glick, S. D., Kuehne, M. E., Maisonneuve, I. M., Bandarage, U. K. & Molinari, H. H. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res. 719, 29\u201335 (1996).","journal-title":"Brain Res."},{"key":"1714_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00406-023-01590-1","volume":"273","author":"JM Rocha","year":"2023","unstructured":"Rocha, J. M., Reis, J. A. S., Buoso, J. C., Hallak, J. E. C. & Dos Santos, R. G. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. Eur. Arch. Psychiatry Clin. Neurosci. 273, 1527\u20131542 (2023).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1714_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41591-023-02705-w","volume":"30","author":"KN Cherian","year":"2024","unstructured":"Cherian, K. N. et al. Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nat. Med. 30, 373\u2013381 (2024).","journal-title":"Nat. Med."},{"key":"1714_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/00952990.2017.1310218","volume":"44","author":"GE Noeller","year":"2018","unstructured":"Noeller, G. E., Frampton, C. M. & Yazar-Klosinski, B. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. Am. J. Drug Alcohol Abuse 44, 37\u201346 (2018).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"1714_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1556\/2054.01.2017.009","volume":"1","author":"AK Davis","year":"2017","unstructured":"Davis, A. K., Barsuglia, J. P., Windham-Herman, A., Lynch, M. & Polanco, M. Subjective effectiveness of ibogaine treatment for problematic opioid consumption: short- and long-term outcomes and current psychological functioning. J. Psychedelic Stud. 1, 65\u201373 (2017).","journal-title":"J. Psychedelic Stud."},{"key":"1714_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1021\/ja01534a035","volume":"80","author":"DF Dickel","year":"1958","unstructured":"Dickel, D. F., Holden, C. L., Maxfield, R. C., Paszek, L. & Taylor, W. The alkaloids of Tabernanthe iboga. Part III. Isolation studies. J. Am. Chem. Soc. 80, 123\u2013125 (1958).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/1057563029001\/4881","volume":"16","author":"CW Jenks","year":"2002","unstructured":"Jenks, C. W. Extraction studies of Tabernanthe iboga and Voacanga africana. Nat. Prod. Lett. 16, 71\u201376 (2002).","journal-title":"Nat. Prod. Lett."},{"key":"1714_CR17","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1021\/acsomega.1c00745","volume":"6","author":"B Gonzalez","year":"2021","unstructured":"Gonzalez, B. et al. Efficient access to the iboga skeleton: optimized procedure to obtain voacangine from Voacanga africana root bark. ACS Omega 6, 16755\u201316762 (2021).","journal-title":"ACS Omega"},{"key":"1714_CR18","doi-asserted-by":"publisher","first-page":"12979","DOI":"10.1021\/jacs.9b05999","volume":"141","author":"SC Farrow","year":"2019","unstructured":"Farrow, S. C. et al. Biosynthesis of an anti-addiction agent from the iboga plant. J. Am. Chem. Soc. 141, 12979\u201312983 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR19","doi-asserted-by":"publisher","first-page":"13821","DOI":"10.1074\/jbc.RA118.004060","volume":"293","author":"SC Farrow","year":"2018","unstructured":"Farrow, S. C. et al. Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga. J. Biol. Chem. 293, 13821\u201313833 (2018).","journal-title":"J. Biol. Chem."},{"key":"1714_CR20","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1021\/ja00480a047","volume":"100","author":"BM Trost","year":"1978","unstructured":"Trost, B. M., Godleski, S. A. & Genet, J. P. A total synthesis of racemic and optically active ibogamine. Utilization and mechanism of a new silver ion assisted palladium catalyzed cyclization. J. Am. Chem. Soc. 100, 3930\u20133931 (1978).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR21","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1248\/cpb.33.4202","volume":"33","author":"T Imanishi","year":"1985","unstructured":"Imanishi, T., Yagi, N. & Hanaoka, M. 1,6-Dihydro-3(2H)-pyridinones. X. 2-Azabicyclo[2.2.2]octane ring formation via intramolecular Michael reaction: total synthesis of (\u00b1)-ibogamine and (\u00b1)-epiibogamine. Chem. Pharm. Bull. 33, 4202\u20134211 (1985).","journal-title":"Chem. Pharm. Bull."},{"key":"1714_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/hlca.200690058","volume":"89","author":"S H\u00f6ck","year":"2006","unstructured":"H\u00f6ck, S. & Borschberg, H. J. Enantioselective synthesis of (\u2212)-(19R)-ibogamin-19-ol. Helv. Chim. Acta 89, 542\u2013557 (2006).","journal-title":"Helv. Chim. Acta"},{"key":"1714_CR23","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1021\/ol3027945","volume":"14","author":"M Harada","year":"2012","unstructured":"Harada, M. et al. Asymmetric total synthesis of an iboga-type indole alkaloid, voacangalactone, newly isolated from Voacanga africana. Org. Lett. 14, 5800\u20135803 (2012).","journal-title":"Org. Lett."},{"key":"1714_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nchem.1798","volume":"6","author":"H Mizoguchi","year":"2013","unstructured":"Mizoguchi, H., Oikawa, H. & Oguri, H. Biogenetically inspired synthesis and skeletal diversification of indole alkaloids. Nat. Chem. 6, 57\u201364 (2013).","journal-title":"Nat. Chem."},{"key":"1714_CR25","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1021\/jo5018102","volume":"80","author":"AC Kruegel","year":"2015","unstructured":"Kruegel, A. C., Rakshit, S., Li, X. & Sames, D. Constructing iboga alkaloids via C\u2013H bond functionalization: examination of the direct and catalytic union of heteroarenes and isoquinuclidine Alkenes. J. Org. Chem. 80, 2062\u20132071 (2015).","journal-title":"J. Org. Chem."},{"key":"1714_CR26","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1021\/acs.orglett.2c02516","volume":"24","author":"G Zhang","year":"2022","unstructured":"Zhang, G. et al. Synthesis of tertiary amines through extrusive alkylation of carbamates. Org. Lett. 24, 6208\u20136212 (2022).","journal-title":"Org. Lett."},{"key":"1714_CR27","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1021\/acs.orglett.3c01595","volume":"25","author":"AJ Hughes","year":"2023","unstructured":"Hughes, A. J. & Townsend, S. D. Gram-scale total synthesis of (\u00b1)-ibogamine. Org. Lett. 25, 4567\u20134570 (2023).","journal-title":"Org. Lett."},{"key":"1714_CR28","doi-asserted-by":"publisher","first-page":"e202400442","DOI":"10.1002\/ejoc.202400442","volume":"27","author":"AJ Hughes","year":"2024","unstructured":"Hughes, A. J. & Townsend, S. D. Total synthesis of tabernanthine and ibogaline: rapid access to nosyl tryptamines. Eur. J. Org. Chem. 27, e202400442 (2024).","journal-title":"Eur. J. Org. Chem."},{"key":"1714_CR29","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1021\/jo00217a052","volume":"50","author":"S Raucher","year":"1985","unstructured":"Raucher, S. & Bray, B. L. Total synthesis of (\u00b1)-catharanthine. J. Org. Chem. 50, 3236\u20133237 (1985).","journal-title":"J. Org. Chem."},{"key":"1714_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jlac.199119910119","volume":"2","author":"C Herdeis","year":"1991","unstructured":"Herdeis, C. & Hartke-Karger, C. Short and stereoselective synthesis of (\u00b1)-ibogamine via a vinylsulfone intermediate, IV. Liebigs Ann. Chem. 2, 99\u2013104 (1991).","journal-title":"Liebigs Ann. Chem."},{"key":"1714_CR31","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ja00965a039","volume":"88","author":"G B\u00fcchi","year":"1966","unstructured":"B\u00fcchi, G., Coffen, D. L., Kocsis, K., Sonnet, P. E. & Ziegler, F. E. The total synthesis of iboga alkaloids. J. Am. Chem. Soc. 88, 3099\u20133109 (1966).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR32","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1016\/j.tet.2012.06.027","volume":"68","author":"GK Jana","year":"2012","unstructured":"Jana, G. K. & Sinha, S. Total synthesis of ibogaine, epiibogaine and their analogues. Tetrahedron 68, 7155\u20137165 (2012).","journal-title":"Tetrahedron"},{"key":"1714_CR33","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1021\/acs.orglett.6b00989","volume":"18","author":"G Zhao","year":"2016","unstructured":"Zhao, G. et al. Bioinspired collective syntheses of iboga-type indole alkaloids. Org. Lett. 18, 2447\u20132450 (2016).","journal-title":"Org. Lett."},{"key":"1714_CR34","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1021\/ol0001463","volume":"2","author":"JD White","year":"2000","unstructured":"White, J. D. & Choi, Y. Catalyzed symmetric Diels\u2212Alder reaction of benzoquinone. Total synthesis of (\u2212)-ibogamine. Org. Lett. 2, 2373\u20132376 (2000).","journal-title":"Org. Lett."},{"key":"1714_CR35","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1021\/ja01001a067","volume":"89","author":"SI Sallay","year":"1967","unstructured":"Sallay, S. I. The total synthesis of dl-ibogamine. J. Am. Chem. Soc. 89, 6762\u20136763 (1967).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1021\/jo01256a065","volume":"34","author":"RL Augustine","year":"1969","unstructured":"Augustine, R. L. & Pierson, W. G. Synthesis of dl-deethylibogamine. J. Org. Chem. 34, 1070\u20131075 (1969).","journal-title":"J. Org. Chem."},{"key":"1714_CR37","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/ol990749i","volume":"1","author":"MT Redding","year":"1999","unstructured":"Redding, M. T. & Fukuyama, T. Stereocontrolled total synthesis of (\u00b1)-catharanthine via radical-mediated indole formation. Org. Lett. 1, 973\u2013976 (1999).","journal-title":"Org. Lett."},{"key":"1714_CR38","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1021\/acs.orglett.2c04287","volume":"6","author":"P Yu","year":"2023","unstructured":"Yu, P., Karmakar, A., Sabbers, W. A., Shajan, F. & Andrade, R. B. Asymmetric total synthesis of (+)-epiibogamine enabled by three-component domino Michael\/Michael\/Mannich annulation of N-sulfinyl metallosilylenamines. Org. Lett. 6, 956\u2013960 (2023).","journal-title":"Org. Lett."},{"key":"1714_CR39","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1021\/ja412342g","volume":"136","author":"K Iwasaki","year":"2014","unstructured":"Iwasaki, K., Wan, K. K., Oppedisano, A., Crossley, S. W. M. & Shenvi, R. A. Simple, chemoselective hydrogenation with thermodynamic stereocontrol. J. Am. Chem. Soc. 136, 1300\u20131303 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR40","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1021\/acs.chemrev.6b00334","volume":"116","author":"SWM Crossley","year":"2016","unstructured":"Crossley, S. W. M., Obradors, C., Martinez, R. M. & Shenvi, R. A. Mn-, Fe-, and Co-catalyzed radical hydrofunctionalizations of olefins. Chem. Rev. 116, 8912\u20139000 (2016).","journal-title":"Chem. Rev."},{"key":"1714_CR41","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1021\/acs.accounts.8b00337","volume":"51","author":"SA Green","year":"2018","unstructured":"Green, S. A. et al. The high chemofidelity of metal-catalyzed hydrogen atom transfer. Acc. Chem. Res. 51, 2628\u20132640 (2018).","journal-title":"Acc. Chem. Res."},{"key":"1714_CR42","doi-asserted-by":"publisher","first-page":"12401","DOI":"10.1039\/D0SC04112B","volume":"11","author":"SL Shevick","year":"2020","unstructured":"Shevick, S. L. et al. Catalytic hydrogen atom transfer to alkenes: a roadmap for metal hydrides and radicals. Chem. Sci. 11, 12401\u201312422 (2020).","journal-title":"Chem. Sci."},{"key":"1714_CR43","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1021\/jacs.6b13155","volume":"139","author":"JC Lo","year":"2017","unstructured":"Lo, J. C. et al. Bond construction from olefins via radicals. J. Am. Chem. Soc. 139, 2484\u20132503 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR44","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1021\/jacs.9b02844","volume":"141","author":"SA Green","year":"2019","unstructured":"Green, S. A., Huffman, T. R., McCourt, R. O., Van Der Puyl, V. & Shenvi, R. A. Hydroalkylation of olefins to form quaternary carbons. J. Am. Chem. Soc. 141, 7709\u20137714 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR45","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1021\/jacs.0c11630","volume":"143","author":"D Qian","year":"2021","unstructured":"Qian, D., Bera, S. & Hu, X. Chiral alkyl amine synthesis via catalytic enantioselective hydroalkylation of enecarbamates. J. Am. Chem. Soc. 143, 1959\u20131967 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR46","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1021\/jacs.5b07770","volume":"137","author":"JD Griffin","year":"2015","unstructured":"Griffin, J. D., Zeller, M. A. & Nicewicz, D. A. Hydrodecarboxylation of carboxylic and malonic acid derivatives via organic photoredox catalysis: substrate scope and mechanistic Insight. J. Am. Chem. Soc. 137, 11340\u201311348 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR47","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1039\/D1SC00528F","volume":"12","author":"N Li","year":"2021","unstructured":"Li, N. et al. A highly selective decarboxylative deuteration of carboxylic acids. Chem. Sci. 12, 5505\u20135510 (2021).","journal-title":"Chem. Sci."},{"key":"1714_CR48","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1021\/acs.jcim.5b00723","volume":"56","author":"T Bottcher","year":"2016","unstructured":"Bottcher, T. An additive definition of molecular complexity. J. Chem. Inf. Model. 56, 462\u2013470 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"1714_CR49","doi-asserted-by":"publisher","first-page":"18599","DOI":"10.1021\/jacs.0c08231","volume":"142","author":"RM Demoret","year":"2020","unstructured":"Demoret, R. M. et al. Synthetic, mechanistic, and biological interrogation of Ginkgo biloba chemical space en route to (\u2212)-bilobalide. J. Am. Chem. Soc. 142, 18599\u201318618 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR50","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1039\/C8QO00849C","volume":"5","author":"SK Kim","year":"2018","unstructured":"Kim, S. K. & Batey, R. A. Enantioselective isoquinuclidine synthesis via sequential Diels\u2013Alder\/visible-light photoredox C\u2013C bond cleavage: a formal synthesis of the indole alkaloid catharanthine. Org. Chem. Front. 5, 2934\u20132939 (2018).","journal-title":"Org. Chem. Front."},{"key":"1714_CR51","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.tet.2011.12.041","volume":"68","author":"C Seki","year":"2012","unstructured":"Seki, C. et al. Asymmetric synthesis of isoquinuclidines by Diels\u2013Alder reaction of 1,2-dihydropyridine utilizing a chiral Lewis acid catalyst. Tetrahedron 68, 1774\u20131781 (2012).","journal-title":"Tetrahedron"},{"key":"1714_CR52","doi-asserted-by":"publisher","first-page":"10879","DOI":"10.1016\/j.tet.2006.08.099","volume":"62","author":"H Nakano","year":"2006","unstructured":"Nakano, H., Tsugawa, N., Takahashi, K., Okuyama, Y. & Fujita, R. An efficient synthetic methodology of chiral isoquinuclidines by the enantioselective Diels\u2013Alder reaction of 1,2-dihydropyridines using chiral cationic palladium\u2013phosphinooxazolidine catalyst. Tetrahedron 62, 10879\u201310887 (2006).","journal-title":"Tetrahedron"},{"key":"1714_CR53","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1016\/S0040-4020(02)00980-8","volume":"58","author":"N Takenaka","year":"2002","unstructured":"Takenaka, N., Huang, Y. & Rawal, V. H. The first catalytic enantioselective Diels\u2013Alder reactions of 1,2-dihydropyridine: efficient syntheses of optically active 2-azabicyclo[2.2.2]octanes with chiral BINAM derived Cr(III) salen complexes. Tetrahedron 58, 8299\u20138305 (2002).","journal-title":"Tetrahedron"},{"key":"1714_CR54","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1246\/cl.2008.924","volume":"37","author":"M Hirama","year":"2008","unstructured":"Hirama, M. et al. Asymmetric cycloaddition of 1,2-dihydropyridine derivatives in the presence of Lewis acids. Chem. Lett. 37, 924\u2013925 (2008).","journal-title":"Chem. Lett."},{"key":"1714_CR55","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1039\/C6SC00932H","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Xue, Y., Li, G., Yuan, H. & Luo, T. Enantioselective synthesis of iboga alkaloids and vinblastine via rearrangements of quaternary ammoniums. Chem. Sci. 7, 5530\u20135536 (2016).","journal-title":"Chem. Sci."},{"key":"1714_CR56","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1021\/ja017641u","volume":"124","author":"AB Nothrup","year":"2002","unstructured":"Nothrup, A. B. & Macmillan, D. W. C. The first general enantioselective catalytic Diels\u2212Alder reaction with simple \u03b1,\u03b2-unsaturated ketones. J. Am. Chem. Soc. 124, 2458\u20132460 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"1714_CR57","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1021\/acs.oprd.9b00124","volume":"23","author":"GL Buetner","year":"2019","unstructured":"Buetner, G. L. et al. Revisiting the cleavage of Evans oxazolidinones with LiOH\/H2O2. Org. Process Res. Dev. 23, 1378\u20131385 (2019).","journal-title":"Org. Process Res. Dev."},{"key":"1714_CR58","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","volume":"25","author":"DY He","year":"2005","unstructured":"He, D. Y. et al. Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J. Neurosci. 25, 619\u2013628 (2005).","journal-title":"J. Neurosci."},{"key":"1714_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2019.00193","volume":"10","author":"S Marton","year":"2019","unstructured":"Marton, S. et al. Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits. Front. Pharmacol. 10, 193 (2019).","journal-title":"Front. Pharmacol."},{"key":"1714_CR60","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly, C. et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 23, 3170\u20133182 (2018).","journal-title":"Cell Rep."},{"key":"1714_CR61","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.cell.2023.04.010","volume":"186","author":"I Singh","year":"2023","unstructured":"Singh, I. et al. Structure-based discovery of conformationally selective inhibitors of the serotonin transporter. Cell 186, 2160\u20132175 (2023).","journal-title":"Cell"},{"key":"1714_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0024-3205(95)00273-9","volume":"57","author":"DC Mash","year":"1995","unstructured":"Mash, D. C., Staley, J. K., Baumann, M. H., Rothman, R. B. & Hearn, W. L. Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci. 57, 45\u201350 (1995).","journal-title":"Life Sci."},{"key":"1714_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF02805969","volume":"127","author":"JK Staley","year":"1996","unstructured":"Staley, J. K. et al. Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine. Psychopharmacology 127, 10\u201318 (1996).","journal-title":"Psychopharmacology"},{"key":"1714_CR64","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0022-3565(24)29567-7","volume":"297","author":"MH Baumann","year":"2001","unstructured":"Baumann, M. H., Rothman, R. B., Pablo, J. P. & Mash, D. C. In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. J. Pharmacol. Exp. Ther. 297, 531\u2013539 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1714_CR65","doi-asserted-by":"publisher","first-page":"29441","DOI":"10.1074\/jbc.M704456200","volume":"282","author":"MT Jacobs","year":"2007","unstructured":"Jacobs, M. T., Zhang, Y. W., Campbell, S. D. & Rudnick, G. Ibogaine, a noncompetitive inhibitor of serotonin transport acts by stabilizing the cytoplasm-facing state of the transporter. J. Biol. Chem. 282, 29441\u201329447 (2007).","journal-title":"J. Biol. Chem."},{"key":"1714_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","volume":"569","author":"JA Coleman","year":"2019","unstructured":"Coleman, J. A. et al. Serotonin transporter\u2013ibogaine complexes illuminate mechanisms of inhibition and transport. Nature 569, 141\u2013145 (2019).","journal-title":"Nature"},{"key":"1714_CR67","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","volume":"61","author":"NA Meanwell","year":"2018","unstructured":"Meanwell, N. A. Fluorine and fluorinated motifs in the design and applicationof bioisosteres for drug design. J. Med. Chem. 61, 5822\u20135880 (2018).","journal-title":"J. Med. Chem."},{"key":"1714_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jcph.404","volume":"55","author":"P Glue","year":"2015","unstructured":"Glue, P. et al. Ascending-dose study of noribogaine in healthy volunteers: pharmacokinetics, pharmacodynamics, safety, and tolerability. J. Clin. Pharmacol. 55, 189\u2013194 (2015).","journal-title":"J. Clin. Pharmacol."},{"key":"1714_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1107\/S0365110X60001369","volume":"13","author":"G Arai","year":"1960","unstructured":"Arai, G., Coppola, J. & Jeffrey, G. The structure of ibogaine. Acta Crystallogr. 13, 553\u2013564 (1960).","journal-title":"Acta Crystallogr."},{"key":"1714_CR70","doi-asserted-by":"publisher","first-page":"727117","DOI":"10.3389\/fpsyt.2021.727117","volume":"12","author":"MV Vargas","year":"2021","unstructured":"Vargas, M. V., Meyer, R., Avanes, A., Rus, M. & Olson, D. E. Psychedelics and other psychoplastogens for treating mental illness. Front. Psychiatry 12, 727117 (2021).","journal-title":"Front. Psychiatry"},{"key":"1714_CR71","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"MV Vargas","year":"2023","unstructured":"Vargas, M. V. et al. Psychedelics promote neuroplasticity through activation of intracellular 5-HT2A receptors. Science 379, 700\u2013706 (2023).","journal-title":"Science"},{"key":"1714_CR72","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1016\/0040-4039(96)01939-9","volume":"37","author":"K Henry","year":"1996","unstructured":"Henry, K., Dubay, J. W. & Grieco, P. A. A novel approach to iboga alkaloids: total synthesis of (\u00b1)-ibogamine and (\u00b1)-epi-ibogamine. Tetrahedron Lett. 37, 8289\u20138292 (1996).","journal-title":"Tetrahedron Lett."},{"key":"1714_CR73","doi-asserted-by":"publisher","unstructured":"Iyer, R. & Olson, D. E. Efficient and modular synthesis of ibogaine and related alkaloids - data sets Prism files. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.24531316 (2024).","DOI":"10.6084\/m9.figshare.24531316"}],"container-title":["Nature Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41557-024-01714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41557-024-01714-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41557-024-01714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T23:02:17Z","timestamp":1741215737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41557-024-01714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1038\/s41557-024-01714-7","relation":{},"ISSN":["1755-4330","1755-4349"],"issn-type":[{"value":"1755-4330","type":"print"},{"value":"1755-4349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"27 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.E.O. is a co-founder of Delix Therapeutics, Inc.; serves as the Chief Innovation Officer and Head of the Scientific Advisory Board; and has sponsored research agreements with Delix Therapeutics. Delix Therapeutics has licensed technology from the University of California, Davis related to analogues of iboga alkaloids. D.E.O., R.N.I. and A.D. have submitted a patent application related to the work described here. The sponsors of this research were not involved in the conceptualization, design, decision to publish or preparation of the manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}